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Abstract
Background: Tissue liquefaction liposuction (TLL) deploys a novel energy source utilizing a stream of warmed, low-pressurized, and pulsed saline 
to extract fat tissue.
Objectives: Compare TLL to suction-assisted liposuction (SAL) to determine which device is more efficient for surgeons and provides better recovery 
for patients.
Methods: Thirty-one adult female patients were followed prospectively in a contralateral study design comparing differences in bruising, swelling, 
tenderness, and incision appearance ratings between TLL and SAL procedures. Surgical efficiency and appearance of the lipoaspirate were also compared.
Results: All 31 patients successfully completed the study. For TLL and SAL procedures, the average volumes of infusion (1.242 vs 1.276 L) and aspi-
rated supernatant fat (704 vs 649 mL) were statistically similar. TLL median fat extraction rate was faster than SAL (35.6 vs 25 mL/min; P < 0.0001), and 
stroke rate was reduced in TLL vs SAL procedures (48 vs 120 strokes/min; P < 0.0001), and both were statistically significant. The mean total scores for 
bruising, swelling, treatment site tenderness, and incision appearance were lower, indicating improved patient recovery on the TLL side.
Conclusions: TLL and SAL techniques produced comparable volume of fat aspirate. TLL demonstrated a 42% faster fat extraction rate and a 68% 
reduction in arm movements needed to complete the procedure compared to SAL, both of these differences are statistically significant. The TLL side was 
noted to have reduced bruising and swelling and improved incision site appearance with less tenderness compared to the SAL side.
Level of Evidence: 2 
Editorial Decision date: December 22, 2017; online publish-ahead-of-print January 23, 2018.
Liposuction is the most popular cosmetic surgery and 
accounted for over 400,000 US procedures in 2016.1 Since 
the introduction of tumescent liposuction in the mid-
1980s,2-4 there have been many technological innovations, 
but in a 2011 survey of 492 US plastic surgeons, suction-as-
sisted liposuction (SAL) was noted to be the preferred 
method of fat removal among respondents.5
This randomized, single-blind, contralateral study 
examined a novel liposuction method: tissue liquefaction 
liposuction (TLL) (HydraSolve, Andrew Technologies, 
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Tustin, CA). In TLL a stream of warmed (37-55°C), low- 
pressurized (300-1100 psi), and pulsed saline is deployed 
inside the cannula (Figure 1). (The saline is not medi-
cated, and it does not exit the cannula into the tissue bed.) 
Subcutaneous tissues are drawn into the interior of the 
cannula by suction where the saline stream impacts these 
tissues and selectively liquefies fat while not liquefying 
blood vessels, nerves, and connective tissue. Liquefaction 
of fat tissue in TLL is a process of cell disaggregation, not 
of emulsification; fat tissue cells are separated into a mul-
ticell suspension composed of small cell clusters that are 
approximately 500 to 2000 μm in diameter.6 It is believed 
that cell disaggregation occurs because of deactivation of 
adhesive glycoproteins that are located on the surface of 
fat cell membranes. The TLL lipoaspirate contains more 
saline than the SAL lipoaspirate; with gravity separation 
the fat tissue rises to the top of the collection container and 
that layer is considered the volume of aspirated fat tissue, 
while the saline layer below is not counted as aspirated fat 
tissue. The quality of TLL harvested fat for autologous fat 
transfer has been demonstrated in several studies,6-11 and 
the device was also FDA 510(k) cleared12 for Autologous 
Fat Transfer in 2013.
The purpose of this study was to compare the efficiency 
of fat extraction and the impact on patient recovery of the 
tissue-selective extraction of fat in TLL vs SAL procedures. 
Participants in the study were randomized to receive TLL 
on one side of the body and standard SAL at corresponding 
treatment sites on the other side of the body, with similar 
extraction volumes in each procedure. The contralateral 
study design allowed patients to act as their own controls, 
thereby reducing or eliminating interpatient variability. The 
fat extraction time, surgeons’ exertion, and overall surgeon 
satisfaction were recorded at the time of the procedure. 
Bruising, swelling, treatment site tenderness, and incision 
appearance were followed for 30 days after treatment.
METHODS
This prospective study followed 31 female patients 
between January and September 2016 who underwent 
liposuction with TLL on one side of the body and SAL on 
the corresponding contralateral treatment site or sites. All 
patients were enrolled and treated by 5 plastic surgeons at 3 
practices, with each surgeon treating at least 4 patients. All 
surgeons were provided with a study check list (Appendix A, 
available online as Supplementary Material at www.aes-
theticsurgeryjournal.com). Investigators performed the 
procedures and conducted postoperative patient assess-
ments in a nonblinded manner. Patients were required to 
sign an informed consent document, and the study was 
conducted in accordance with protocols approved by the 
Western Institutional Review Board.
To be considered for enrollment, body mass index (BMI) 
between 19 and 30 kg/m2 and suitable fat deposits were 
required. Enrollment required a negative urine pregnancy 
test and patients were instructed to discontinue use of 
birth control pills, nonsteroidal anti-inflammatory drugs, 
and any blood thinners for 3 weeks prior and 2 weeks after 
surgery. Additionally, patients consented to be followed for 
30 days following surgery.
Patients were excluded from the study for: prior liposuc-
tion or surgery in the surgical area, redundant or inelastic 
skin, diabetes mellitus or cardiovascular disease, coagu-
lation disorder or history of excessive bleeding, a history 
of or current narcotic use, a diagnosis of fibromyalgia, 
American Society of Anesthesiologists level 3 or higher, 
body dysmorphic syndrome, or a large tattoo that could 
obscure the presence or absence of bruising.
Liposuction surgery was performed on each side of the 
patient’s body, with any of the following anatomic sites eli-
gible: abdomen (lower or upper); thighs (medial, anterior, 
or lateral); or the waist, flanks, or hips. Prior to surgery, a 
coin flip was used to determine which technique was used 
first (TLL, heads; SAL, tails), and the left side was always 
treated first. All surgeries were performed under general 
anesthesia using “superwet technique.”13
Prior to the first side being operated, an incision was 
made and a solution containing 0.25% bupivacaine with 
1:200,000 epinephrine was injected using a 27-gauge nee-
dle. Standard tumescent infusion solution containing epi-
nephrine (final dilution of 1:1,000,000) was infused at a 
volume approximately equal to the volume of fat to be 
removed.
Figure 1. Tissue liquefaction liposuction (TLL) cannula schematic (reprinted with permission from Andrew Technologies).
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Surgeons were instructed to wait 12 minutes before 
performing treatment with the first device. After the con-
clusion of the left treatment side, injection of tumescent 
solution, followed by a 12-minute wait time, was repeated 
before treating the right side with the other device.
For the TLL portion of the procedure, a 22.0-cm long can-
nula (HydraSolve; Tustin, CA) with a 3.0-mm outer diameter 
and two apertures was used. Per protocol, TLL was per-
formed using phaser stream settings of 1100 psi and 46°C. 
For the SAL side, a Mentor (Byron, Irvine, CA) 3.0-mm 
outer diameter, three aperture, 26.0-cm Mercedes cannula 
(Mentor Catalog # MER326S) was used. Extracted lipoaspi-
rate from each device was collected in separate waste can-
isters, which were allowed to gravity separate for two hours 
before measuring the amount of settled supernatant fat.
Measurements and Outcomes
All surgical outcomes were recorded using a “SURGEON 
REPORT FORM” and recovery assessments were recorded 
using an “INVESTIGATOR ASSESSMENT FORM” 
(Appendices B-C, available online as Supplementary 
Material at www.aestheticsurgeryjournal.com). For each 
device, total fat extraction time was recorded using a stop-
watch. Stroke rate for each device was recorded by averag-
ing the number of strokes performed in a 10-second period 
in two separate intervals. (An OR technician announced 
the start of a 10 second interval on a stopwatch while the 
surgeon counted out loud the number of strokes.) Patients 
were required to return for follow-up visits on postoper-
ative day 1 and again on postoperative days 4 to 6; 8 to 
10; and 29 to 31. At each clinical visit, the incision and 
treatment sites were observed and photographed. The 
treatments were complimentary for enrolled patients, and 
they were compensated for showing up for their follow-up 
visits, to assure compliance in completing the study.
Statistical Methods
The primary endpoint was the total score of bruising, swell-
ing, tenderness, and incision appearance ratings recorded 
on the INVESTIGATOR ASSESSMENT FORM. The repeated 
measures of total scores at visits 1, 2, and 3 for each treat-
ment side were analyzed in a linear mixed effects model 
incorporating the random effects of patient and visit; and 
fixed effects of surgeon, visit, and treatment side. The inter-
actions between visit and treatment side and between sur-
geon and treatment side were also considered. The normal 
distribution assumption necessary for validity of the linear 
mixed effects model was appropriate for the total scores.
For the majority of endpoints from the SURGEON 
REPORT FORM (lipoaspirate appearance, supernatant 
appearance, physical exertion, overall surgeon satisfac-
tion, and lipoaspirate flow dynamics), the assumption 
of normal distribution was not appropriate for the ordi-
nal ratings between 1 and 10 or their differences between 
TLL and SAL side. Therefore, the difference between TLL 
and SAL side was analyzed using the nonparametric (not 
requiring the normal distribution assumption) Wilcoxon 
signed rank test and by computing the 95% confidence 
intervals for the median paired differences.
In secondary analysis, fat extraction rates for both 
treatment sides were analyzed in a linear mixed effects 
model incorporating the random effects of patient and 
fixed effects of surgeon, treatment side, and interaction 
between surgeon and treatment side. The normal distribu-
tion assumptions necessary for validity of the linear mixed 
effects model were appropriate.
Using the conservative Bonferroni adjustment for 
multiple testing, we concluded that the difference be-
tween SAL and TLL side was significant if the P value 
for the test of the treatment difference was less than 
alpha=0.05/14=0.00357. This allowed controlling for the 
family wise type I error at 0.05 level.
RESULTS
All of the 31 patients successfully completed the study 
and no complications were reported. All 31 patients in the 
study were available for analysis at all time points with 
one exception: one patient missed her last follow up visit 
(day 29-31), she was present for the first three postopera-
tive visits (postoperative day 1, days 4-6, and days 8-10). 
All patients were female with an average age of 38.5 years 
(range, 26-54 years). Average height was 165.68 cm (range, 
152.4-180.34 cm) and average weight was 68.93 kg (range, 
51.71-92.53 kg) with a mean BMI of 25.1 kg/m2 (range, 
21.3-29.8 kg/m2). Each patient was seen 4 times posttreat-
ment to assess results, with the one exception already 
mentioned, where one patient missed the last visit at 29 to 
31 days postoperative. Visit 1 occurred at posttreatment day 
1 for all patients. Visit 2 averaged 5.3 days posttreatment 
(range, 4-7 days). Visit 3 averaged 8.3 days posttreatment 
(range, 8-10 days). Visit 4 averaged 29.5 days posttreat-
ment (range, 29-32 days). The average volume of tumes-
cent infusion fluid used in SAL procedures was 1.276 L 
(range 250-3100 mL) and the average volume of aspirated 
fat was 649 mL (range 200-1100 mL). The average volume 
of tumescent infusion fluid used in TLL procedures was 
1.242 L (range 250-3100 mL) and the average volume of 
aspirated fat was 704 mL (300-1100 mL).
Investigator Assessment Form
When averaged across the surgeons, the mean total 
scores for bruising, swelling, treatment site tenderness, 
and incision appearance were lower (indicating more 
favorable scores) on the TLL side by 2.09 (95% CI: 1.04, 
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2.97, P < 0.0001) and the difference was statistically sig-
nificant. This difference corresponded to a 16% lower 
mean total score for the TLL side (11.4; 95% CI: 10.7, 
12.2) compared to the SAL side (13.1; 95% CI: 12.4, 13.9) 
(Figures 2-5).
Surgical Efficiency
The median fat extraction rate was 35.6 cc/min in TLL 
procedures vs 25 cc/min in SAL procedures (P < 0.0001), 
resulting in a 42% (P < 0.0001) faster fat extraction rate 
in the TLL side. Stroke rate was lower in the TLL vs SAL 
sides. The median stroke rate during TLL procedures was 
48 strokes per minute compared to 120 strokes per minute 
with SAL (P < 0.0001), representing a 68% reduction in 
the number of arm movements by the surgeon when using 
TLL compared to SAL. Physical exertion as measured by 
surgeon survey was significantly better in TLL procedures 
(median score of 3 out of 10, with lower score indicating 
less perceived exertion) as compared to SAL procedures 
(median score of 8 out of 10; P < 0.0001).
Lipoaspirate Appearance
Appearance of the lipoaspirate and supernatant, as well 
as overall satisfaction with the quality of the extracted fat 
and lipoaspirate flow dynamics, were judged by the partic-
ipating surgeons to be superior with TLL compared to SAL 
procedures (Figures 6 and 7). On a 10-point scale, with 
higher values indicating less satisfaction, median scores 
for lipoaspirate and supernatant appearance were 2 and 2, 
respectively, for TLL, compared to 7 and 8, respectively, for 
SAL (P < 0.0001). Likewise, the median score for lipoaspi-
rate flow dynamics was 1 in the TLL group compared to 
8 in the SAL group (P < 0.0001). On a 10-point scale, 
with higher values indicating more satisfaction, surgeons 
A B
C D
Figure 2. (A, C) Preoperative photographs of a 36-year-old woman. (B) Suction-assisted liposuction (SAL)-treated right side 
on day 7 and (D) Tissue liquefaction liposuction (TLL)-treated left side on day 7.
984 Aesthetic Surgery Journal 38(9)
indicated greater satisfaction (median score of 9) with TLL 
compared to SAL (median score of 6; P < 0.0001).
DISCUSSION
The objective of this study was to demonstrate differences 
in surgical efficiency for surgeons and in post-treatment 
recovery for patients; this is the first study to show superi-
ority across several clinical parameters for a new aesthetic 
body contouring device compared to standard suction-as-
sisted lipoplasty (Table 1). This study was not designed 
(powered and long enough follow-up period) to evalu-
ate the aesthetic outcome of these two devices; however, 
that was not the purpose of this study. The purpose of the 
study was to compare the procedural efficiency of TLL for 
surgeons and the recovery experience for patients to stand-
ard suction-assisted lipoplasty.
The physical impact of the selected treatment device 
on various tissues in the subcutaneous space during fat 
extraction may have important implications for patient 
recovery, as this may correlate with the degree of iatro-
genic trauma. One interpretation of the results of this 
study is that because TLL’s mechanism of fat tissue 
removal is more target tissue specific compared to SAL it 
is therefore likely to reduce collateral, nonfat tissue dam-
age. Furthermore, the lower stroke rate in TLL procedures 
and slower surgeon movements also likely contributed to 
less potential for trauma at the surgical site, both inside 
the subcutaneous space and at the incision site. The fewer 
arm movements required by the surgeons to extract fat 
also represented a reduction in the level of physical exer-
tion, with potential to lessen the risk of repetitive stress on 
surgeons’ joints.
Prior to the introduction of blunt tip cannulae, 
lipoplasty procedures were often performed using sharp 
A B
C D
Figure 3. (A, C) Preoperative photographs of a 44-year-old woman. (B) Suction-assisted liposuction (SAL)-treated left side on 
day 4 and (D) Tissue liquefaction liposuction (TLL)-treated right side on day 4.
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curettage with large sections of fat and surrounding tis-
sue mechanically sheared and suctioned from the surgi-
cal site.14 However, these procedures were associated with 
significant morbidity, not insignificant rates of mortality, 
and, especially when dry techniques were employed, a 
high degree of blood loss.14-20 Although tumescent and 
superwet techniques are associated with easier removal of 
fat cells, they do not address the need for a more target 
tissue specific mechanism of action of extracting fat tissue 
in liposuction which would reduce iatrogenic trauma to 
nonfat tissue.
The target tissue specific liquefaction of fat by TLL 
is made possible by using a novel energy source for 




Figure 4. (A, D, G, J) Preoperative photographs of a 54-year-old woman. Suction-assisted liposuction (SAL)-treated right side 
on days 8 (B, H) and 30 (C, I). Tissue liquefaction liposuction (TLL)-treated left side on days 8 (E, K) and 30 (F, L).
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Originally invented for use in cataract extraction,21 tissue 
liquefaction technology describes the use of a warmed, 
low-pressurized, and pulsed saline stream to liquefy tar-
get surgical tissue leaving nontarget tissue unchanged. In 
TLL, subcutaneous fat tissue is drawn inside the cannula 
where fat cells are disaggregated by the energized saline 
stream, which results in fat being separated into numer-
ous smaller cell clusters. Blood vessels, nerve fibers, and 
connective tissue are not liquefied in this process and 
they remain in the subcutaneous space in a solid state 
of matter.6 This mechanism significantly minimizes the 
physical exertion necessary to remove fat. As suggested 
by the results of the current study, this less traumatic fat 
removal may have significant benefits for healing, man-






Hunstad et al 987
In the study population, ecchymosis was significantly 
reduced in the TLL group; however, the propensity to 
develop noticeable skin contusions was highly variable. 
Some degree of ecchymosis would be expected following 
any lipoplasty due to the invasive nature of the procedure. 
Yet, in the present study, there was significant interpatient 
variability in the extent of and propensity to develop ecchy-
mosis. Because patients served as their own controls, any 
potential for known or unknown factors to confound the 
results is greatly diminished, especially as the potential for 
bruising would likely be equal on each side of the body.
Although SAL is still widely used in lipoplasty proce-
dures, many surgeons have adopted other mechanisms 
for subcutaneous fat extraction. Future studies with TLL 
should examine potential differences in outcomes relative 
to other technologies. For purposes of the current study, 
using SAL as a comparator is reasonable, as it may well rep-
resent the current standard of care in lipoplasty procedures.
A B
C
Figure 5. (A) Preoperative photograph of a 54-year-old woman (the same patient as in Figure 4). Her right side was 
treated with Suction-assisted liposuction (SAL) and her left side was treated with Tissue liquefaction liposuction (TLL). (B) 
Postoperative photograph at day 8. (C) Postoperative photograph at day 30.
Table 1. Results for the Primary Endpoints from the SURGEON REPORT FORM
Endpoint TLL side (median) SAL side (median) Difference SAL vs TLL (95% CI)a % Differenceb,c
No. of strokes/min 48 120 −81.0 (−72.0 to −99.0) 68% (P < 0.0001)
Total no. of strokes 838 3078 +1909 (+1689 to +2752) 62% (P < 0.0001)
No. of arm movements/min 96 240 +162 (+144 to +198) 68% (P < 0.0001)
Fat extraction rate (cc/min) 35.6 25.0 +10.6 42% (P < 0.0001)
SAL, suction-assisted liposuction; TLL, tissue liquefaction. a confidence intervals for the median differences b % difference between HS and SAL as compared to SAL. If negative: % decrease in 
HS as compared to SAL; If positive: % increase in HS as compared to SAL. c All reported P-values are less than alpha (Type I error) of 0.00417 as required for significance using the Bonferroni 
correction for multiple testing
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Subanalysis of surgical times from individual sur-
geons suggested a trend toward shorter extraction time 
using TLL in late vs early cases (data not shown). This 
is suggestive of a learning curve that may confound the 
results of the study. As well, the study enrolled relatively 
small numbers of patients and the duration of the study 
was short.
Nevertheless, for the purposes of studying postopera-
tive healing and surgical efficiency of two technologies, 
both the number of patients and length of follow up were 
entirely appropriate.
The single blind nature of the study introduces the 
potential for confirmational bias. However, patients who 
participated in this study enrolled with the expectation 
for a quality aesthetic outcome on each side of the body, 
and participating surgeons were highly motivated to de-
liver on that promise, which reduces the potential for 
investigator bias.
A limitation of the study was the usage of a coin flip for 
randomization; a random number generator or randomiza-
tion software perhaps could have been a better choice to 
guide randomization in the study.
The contralateral, multicenter, and multiple surgeon 
study design also helps to address potential for investigator 
bias. While surgical technique is a critically important el-
ement in final outcome, results from individual surgeons 
tended to cluster around the median finding, with few if 
any substantial outliers. The suggested uniformity in the 
results with TLL and SAL irrespective of the operator lends 
credibility to the findings and discounts the prospect of 
preconceived notions affecting results.
We have observed many plastic surgeons performing 
SAL and TLL. How fast they move the cannulae in these 
two types of body contouring methodologies is a function 
of the mechanism of fat removal: in SAL, it is cutting and 
shearing of tissue, in TLL it is the target tissue specific 
liquefaction of fat tissue. The typical stroke rate of a sur-
geon doing SAL is about 2.5 strokes every 1 second. The 
recommended stroke rate for TLL is: 1 stroke every 1.5 to 
2 seconds as TLL removes fat most efficiently with that 
stroke rate. In a 10 second interval, the SAL stroke rate will 
usually be somewhere between 18 and 30, and the TLL 
stroke rate will be between 4 and 8 in a 10 second interval. 
We have observed that all you need is a 10 second interval 
to document this, because the stroke rates are consistent 
throughout the vast majority of the procedure, for both SAL 
and TLL.
Comparison of the quality of the aspirate was not the 
primary purpose of the study, so that is the main reason a 
more rigorous scientific methodology was not employed to 
characterize the blood content of the lipoaspirates. Early 
in the study design, the company did consult a Ph.D. cell 
biologist to help us determine if we could reliably perform 
a quantitative analysis of the hematocrit and hemoglobin 
levels in the lipoaspirates.
We took fresh TLL and SAL lipoaspirates and analyzed 
them in a Beckman Coulter Counter (Beckman Coulter, Inc., 
Life Science Division Headquarters, Indianapolis, USA). 
We found that this method was not scientifically valid. We 
came to the conclusion that to obtain scientifically accu-
rate blood content measurements of lipoaspirates that we 
would have to develop a new protocol ourselves. Since 
the main purpose of the study was not about lipoaspirate 
quality, nor about the blood content of lipoaspirates, we 
decided to develop that methodology at a later date for a 
later study.
In this study, a superwet technique using a solution 
of bupivacaine with epinephrine was used based on the 
preference of one of the surgeons in the study, and all the 
other study surgeons agreed with it. It was not done to 
Figure 7. Tissue liquefaction liposuction (TLL) abdomen settled fat 
in waste canister.
Figure 6. Suction-assisted liposuction (SAL) abdomen settled fat 
in waste canister.
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minimize blood in the lipoaspirate. There was no waiting 
after this step was done, before the tumescent infusion 
was started.
CONCLUSION
This study demonstrated that TLL and SAL were each 
equally viable for moderate volume fat removal during 
liposuction procedures, while the former demonstrated 
a 42% faster fat extraction rate and a 68% reduction in 
arm movements needed to complete the procedure. The 
TLL side was noted in the first three postoperative visits 
to have reduced bruising, swelling, treatment site tender-
ness, and a better incision site appearance compared to 
the SAL side. Future studies should seek to enroll larger 
numbers of patients and should consider cases involving 
higher volume aspiration and/or body sites with tradition-
ally more fibrous tissue depositions. Longer-term studies 
would be necessary to understand the implications of the 
current study in the context of final outcomes and overall 
aesthetic contour at the operative sites.
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